INMED PHARMACEUTICALS INC. Shares Outstanding (Cover Page)
INMED PHARMACEUTICALS INC. (INM) had Shares Outstanding (Cover Page) of 5.49 million shares as of 2026-09-02, per its 10-K filed 2026-09-09.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-09-09
- 2026-09-02: Entity Common Stock, Shares Outstanding 5.49M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 3.31M shares.
- 2026-02-09: Entity Common Stock, Shares Outstanding 2.92M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 2.80M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-09-02 | 5.49M shares 10-K · filed 2026-09-09 |
| 2026-05-04 | 3.31M shares 10-Q · filed 2026-05-06 |
| 2026-02-09 | 2.92M shares 10-Q · filed 2026-02-11 |
| 2025-10-31 | 2.80M shares 10-Q · filed 2025-11-06 |
| 2025-09-17 | 2.38M shares 10-K/A · filed 2025-10-24 |
| 2025-05-09 | 1.21M shares 10-Q · filed 2025-05-12 |
| 2025-02-07 | 1.21M shares 10-Q · filed 2025-02-12 |
| 2024-11-14 | 718.03K shares 10-Q · filed 2024-11-14 |
| 2024-09-20 | 13.34M shares 10-K · filed 2024-09-30 |
| 2024-02-13 | 6.06M shares 10-Q · filed 2024-02-13 |
| 2023-11-10 | 5.25M shares 10-Q · filed 2023-11-14 |
| 2023-09-29 | 3.33M shares 10-K/A · filed 2023-12-21 |
| 2023-05-15 | 3.33M shares 10-Q · filed 2023-05-15 |
| 2023-02-17 | 3.33M shares 10-Q · filed 2023-02-17 |
| 2022-11-14 | 936.76K shares 10-Q · filed 2022-11-14 |
| 2022-09-23 | 908.76K shares 10-K/A · filed 2022-09-28 |
| 2022-05-13 | 14.64M shares 10-Q · filed 2022-05-13 |
| 2022-02-14 | 14.14M shares 10-Q · filed 2022-02-14 |
| 2021-11-10 | 14.14M shares 10-Q · filed 2021-11-10 |
| 2021-09-24 | 9.38M shares 10-K · filed 2021-09-24 |
| 2021-05-13 | 8.05M shares 10-Q · filed 2021-05-13 |
| 2021-02-11 | 7.00M shares 10-Q · filed 2021-02-11 |
| 2020-12-15 | 7.00M shares 10-Q · filed 2020-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |